Arthroscopic surgery in middle-aged and older patients is ‘difficult to justify’ Picture credit: SPL Researchers reviewed the results of 18 studies on the benefits and harms of arthroscopic surgery for knee pain in patients with and without osteoarthritis compared with control treatments ranging from placebo surgery to exercise. The average age of patients ranged from 48 to 63 years, with follow-up time between three and 24 months. Overall, surgery was associated with a small but significant effect on pain at three and six months, but no longer, compared with control treatments. No significant benefit on physical function was found. A further nine studies reporting on harms found that, although rare, deep vein thrombosis was the most frequently reported adverse event, followed by infection, pulmonary embolism and death. The researchers point out that the benefit from arthroscopy was ‘markedly smaller than that seen from exercise therapy’. They conclude that the findings do not support arthroscopic surgery as a treatment for this group of patients. In a related editorial ( www.bmj.com/cgi/doi/10.1136/bmj.h2983 ), Andy Carr from the Oxford University Institute of Musculoskeletal Sciences, says: ‘It is difficult to justify a procedure with the potential for serious harm, even if it is rare, when that procedure offers patients no more benefit than placebo.’
Nursing Standard – Royal College of Nursing (RCN)
Published: Jun 24, 2015
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera